डैप्टोमाइसिन के इंटरैक्शन
हम जिन FDA लेबल और फैक्ट शीट को इंडेक्स करते हैं, उनमें डैप्टोमाइसिन (Cubicin; एंटीबायोटिक) के 32 इंटरैक्शन दर्ज हैं: 0 गंभीर, 32 मध्यम, 0 मामूली, और 0 ऐसे जिनमें लेबल बताता है कि कोई महत्वपूर्ण इंटरैक्शन नहीं है। नीचे की हर प्रविष्टि उस वाक्य को उद्धृत करती है जिस पर वह आधारित है। दवा का यह पेज एक शुरुआती बिंदु है, आपकी स्थिति के लिए कोई फ़ैसला नहीं।
लेबल से लिए गए इंटरैक्शन
मध्यम इंटरैक्शन (32)
In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)
आप जो कुछ भी लेते हैं, उस सबके साथ डैप्टोमाइसिन को जांचें। अपनी पूरी सूची जोड़ें; हर जोड़ी एक साथ जांची जाती है।
चेकर में खोलेंयह चिकित्सकीय सलाह नहीं है। गंभीरता लेबल के शब्दों को दर्शाती है, आपकी परिस्थितियों को नहीं। “गंभीर” चिह्न वाला संयोजन डॉक्टर की देखरेख में सामान्य बात हो सकता है, और “मामूली” चिह्न वाला संयोजन ऊंची खुराक पर मायने रख सकता है। फार्मासिस्ट से पूछें।